- Home
- CRVO vs GAN Comparison
CRVO vs GAN Comparison
Compare CRVO & GAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- GAN
- Stock Information
- Founded
- CRVO 2001
- GAN 1999
- Country
- CRVO United States
- GAN United States
- Employees
- CRVO N/A
- GAN N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- GAN Computer Software: Programming Data Processing
- Sector
- CRVO Health Care
- GAN Technology
- Exchange
- CRVO Nasdaq
- GAN Nasdaq
- Market Cap
- CRVO 95.4M
- GAN 81.1M
- IPO Year
- CRVO N/A
- GAN 2020
- Fundamental
- Price
- CRVO $8.90
- GAN $1.79
- Analyst Decision
- CRVO Strong Buy
- GAN
- Analyst Count
- CRVO 8
- GAN 0
- Target Price
- CRVO $25.43
- GAN N/A
- AVG Volume (30 Days)
- CRVO 455.4K
- GAN 85.0K
- Earning Date
- CRVO 05-20-2025
- GAN 05-16-2025
- Dividend Yield
- CRVO N/A
- GAN N/A
- EPS Growth
- CRVO N/A
- GAN N/A
- EPS
- CRVO N/A
- GAN N/A
- Revenue
- CRVO $9,737,974.00
- GAN $134,998,000.00
- Revenue This Year
- CRVO N/A
- GAN $12.60
- Revenue Next Year
- CRVO N/A
- GAN $5.02
- P/E Ratio
- CRVO N/A
- GAN N/A
- Revenue Growth
- CRVO 36.29
- GAN 4.31
- 52 Week Low
- CRVO $1.80
- GAN $1.20
- 52 Week High
- CRVO $25.69
- GAN $1.90
- Technical
- Relative Strength Index (RSI)
- CRVO 48.85
- GAN 55.33
- Support Level
- CRVO $8.40
- GAN $1.78
- Resistance Level
- CRVO $11.79
- GAN $1.82
- Average True Range (ATR)
- CRVO 0.96
- GAN 0.03
- MACD
- CRVO -0.15
- GAN 0.01
- Stochastic Oscillator
- CRVO 14.75
- GAN 70.00
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About GAN GAN Limited
GAN Ltd provides Software-as-a-Service solutions for online casino gaming and sports betting applications. The company has two operating segments B2B and B2C. The B2B segment develops, markets, and sells instances of GameSTACK, GAN Sports, and iSight Back Office technology that incorporates comprehensive player registration, account funding, and back-office accounting and management tools that enable the casino operators to efficiently, confidently, and effectively extend their presence online in places that have permitted online real money gaming, and The B2C segment, which includes the operations of Coolbet, develops and operates a B2C online sports betting and casino platform that is accessible through its website in markets across Northern Europe, Latin America, and Canada.